Check Cap Stock

Check Cap EBITDA per Employee

The EBITDA per Employee of Check Cap (MBAI) as of Jul 19, 2026 is -143,092.31 USD. In the previous year, EBITDA per Employee was -271,569.23 USD — a change of -47.31% (higher).

EBITDA per Employee

-143,092.31USD

YoY

-47.31%

Last updated:

EBITDA per Employee of Check Cap is 2026 -143,092.31 USD. EBITDA per Employee of Check Cap was 2025 -271,569.23 USD. It decreases by -47.31% higher compared to the previous year.
Access this data via the Eulerpool API

Check Cap Stock analysis

What does Check Cap do? Check Cap Ltd is an international biotech company specializing in the development of non-invasive diagnostic technologies for early detection of colon cancer. The company is headquartered in Israel and was founded in 2004. Check Cap is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Check Cap stock

EBITDA per Employee of Check Cap is -143,092.31 USD in 2026.

Access this data via the Eulerpool API

Workforce — Check Cap

All Key Metrics — Check Cap